Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Charbone Hydrogen Announces Q2 2025 Financial Results August 30, 2025 Charbone Hydrogene annonce les resultats financiers T2 2025 August 30, 2025 Top 5 Canadian Mining Stocks This Week: Trifecta Shines with 117 Percent Gain August 30, 2025